RBI Aktienanleihe XD4 26.03.2025/ AT0000A3CNS5 /
06/06/2024 9:15:35 | Diferencia+0.080 | Bid14:36:10 | Ask14:36:10 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
109.000EUR | +0.07% | 108.940 Volumen de oferta: 50,000 |
109.190 Tamaño/ Volumen/ Formato de Ask: 50,000 |
STRABAG SE | 40.00 EUR | 26/03/2025 | Call |
GlobeNewswire
14:54
From Rodeo Drive to Malibu Beaches: Luxury Land Rover Defender and Beach Runner Define Sophisticated...
GlobeNewswire
14:53
U.S. direct air capture company CarbonCapture Inc. secures lease for world’s first DAC manufacturing...
GlobeNewswire
14:52
RedCrow and Republic Forge Strategic Partnership to Transform Healthcare Crowdfunding
GlobeNewswire
14:51
Pairwise Grants License to Proprietary Fulcrum™ Platform Tools to Solis Agrosciences for Custom Rese...
GlobeNewswire
14:51
NordPass integrates with Vanta: Offers a straightforward way to automate compliance data
GlobeNewswire
14:45
OkayCoin Expands Profitable Ethereum Staking Options to Enhance Investment Opportunities
GlobeNewswire
14:45
Itron Collaborates with VODA.ai to Pinpoint Water Pipe Failure with Artificial Intelligence
GlobeNewswire
14:35
Safety Shot Partners with Capital Drugs To Launch World’s First Beverage To Reduce Blood Alcohol Con...
GlobeNewswire
14:35
KCSA Cannabis Virtual Investor Conference Presentations Now Available for Online Viewing
GlobeNewswire
14:31
Mama’s Creations to Expand Offering with Multiple New Products and Flavors at IDDBA 2024
GlobeNewswire
14:30
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024
GlobeNewswire
14:30
MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness an...
GlobeNewswire
14:30
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página